
We're absolutely delighted to share this exciting news from the @uniQure_NV AMT-130 trial ucl.ac.uk/news/2025/sep/gene…

Committed to training the next generation of scientists and clinicians to contribute to the fight against Huntington's disease 🧬 @UCLIoN

We're absolutely delighted to share this exciting news from the @uniQure_NV AMT-130 trial ucl.ac.uk/news/2025/sep/gene…

Check out the August 2026 edition of the #HD Clinical Trials Update, published today in @journal_hd and freely available online! 🔓 journals.sagepub.com/doi/10.… Thank you to Profesors Ed Wild, Sarah Tabrizi and Dr @OpeyemiKinyomi, as well as Professors Leslie Thompson and Blair Leavitt for their contributions.

We’re recruiting a Senior Research Technician to work on Huntington’s disease and DNA repair modifier biology. A fantastic opportunity to be part of Prof Sarah Tabrizi’s collaborative lab team at @UCLIoN @UKDRI. Apply here by 26 May👇 ucl.ac.uk/work-at-ucl/search…

The UCL HD Centre is recruiting: Executive Assistant to Professor Sarah Tabrizi (maternity cover). Deadline for applications is 6 May. Apply here: ucl.ac.uk/work-at-ucl/search…

This week, a team shows that lowering the highly toxic Htt1a transcript with siRNA delays #Huntingtin aggregation and corrects transcriptional dysregulation more effectively than targeting full-length, mutant HTT. @UCLHD #HuntingtonsDisease scim.ag/4uZoOer

Still feels surreal to say that I successfully defended my PhD viva with no corrections. Huge thanks to my examiners (Prof Rosser and Prof Rohrer) and to my incredible supervisors (Prof Tabrizi, Prof Scahill and Prof Wild) for their guidance and support throughout this journey. I’m also forever grateful to everyone @UCLHD @UCLIoN who supported me along the way. As written in my thesis dedication: for the #HD community. #PhDone 🥳

This #IWD2026 we spotlight Prof Sarah Tabrizi - leader in #Huntingtonsdisease research and long-standing BNA member. Sarah reflects on: • Resilience in long-term research • Her connection with patients • Advice for ECRs @UCLIoN @ucl @UCLHD youtu.be/SPQ5a4Qn7CM

The current HD-ISS doesn't incorporate wet biomarkers. Dr. Mena Farag discusses the promising results of proenkephalin and other biomarkers to help monitor the earliest stages of HD before the onset of motor symptoms. @MDJ_Journal movementdisorders.org/Podcas…

So much @UCLHD love at my leaving do! Thank you to everyone who made the last three years of my PhD journey such a joy. @UCLBrainScience @UCLIoN


Our featured article for January is a Review on somatic CAG expansions and the potential for therapeutic interventions, from Sarah Tabrizi and colleagues. Free to read here: rdcu.be/eXFmV

Discovery of disrupted sustained attention and altered functional connectivity in far‐from‐onset Huntington's disease gene‐expanded young adults alz-journals.onlinelibrary.w…

Discovery of disrupted sustained attention and altered functional connectivity in far‐from‐onset Huntington's disease gene‐expanded young adults - Langley - 2026 - Alzheimer's & Dementia - Wiley Online Library alz-journals.onlinelibrary.w…

Titans of Science returns with Edward Wild and Sarah Tabrizi (@ucl, @UCLHD and @UCLIoN), who recently announced that Huntington's disease had been successfully treated for the first time. #Huntingtons #TitansOfScience #BrainHealth #Genetics thenakedscientists.com/podca…

Congratulations @DrMFarag from @UCLHD! 👏 @UKDRI @UCLIoN @UCLBrainScience @ucl ucl.ac.uk/brain-sciences/new…

1/5 Sarah Tabrizi (@UCLHD)🇬🇧 Focus: Neurodegenerative Disease Nature calls her a "Hero." Our map shows why: She sits at the perfect intersection of basic neurology and clinical application. Look at the density of her clinical trial connections compared to pure lab research. 🔗 bohrium.com/scholar/4236B15O… #Huntingtons #Neurology #ClinicalResearch